Capricor Therapeutics
CAPR
#7115
Rank
C$0.92 B
Marketcap
C$15.98
Share price
26.49%
Change (1 day)
83.91%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024C$3.82 M4.07%
2023C$3.67 M24.67%
2022C$2.94 M-49.93%
2021C$5.88 M-88.57%
2020C$51.49 M573.14%
2019C$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
C$0.18 BC$0.40 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$4.15 MC$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$16.82 MC$0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$2.91 MC$12.62 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$2.44 MC$3.76 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AC$4.49 M๐Ÿ‡บ๐Ÿ‡ธ USA